MILAN (Reuters) - The worst-ever single day drop in AstraZeneca shares following a drug study failure dominated trading activity at the European open on Thursday though a handful of well-received corporate results helped broader indexes nudge higher.
from Reuters: Top News http://uk.reuters.com/article/uk-europe-stocks-idUKKBN1AC0WK?feedType=RSS&feedName=topNews
No comments:
Post a Comment